Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_assertion type Assertion NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_head.
- NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_assertion description "[In vivo, EGFR signaling is hyperactive in tumor cells of skin SCC but not of BCC, and in nearby asymptomatic epidermis of both tumor types/is due to upregulation of EGFR ligands AREG, HBEGF and TGFA, and downregulation of BTC ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_provenance.
- NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_assertion evidence source_evidence_literature NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_provenance.
- NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_assertion SIO_000772 17525275 NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_provenance.
- NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_assertion wasDerivedFrom lhgdn-20090331 NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_provenance.
- NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_assertion wasGeneratedBy ECO_0000203 NP225572.RAX19ge-vhLgyRw3JknzlHoEL8ZlZw0K2m0T7Xw1o3R30130_provenance.